According to IMARC Group latest report titled “Neurorehabilitation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on neurorehabilitation devices market size. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global neurorehabilitation devices market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 10.5% during 2023-2028.

Neurorehabilitation devices are specialized medical instruments designed to aid in the recovery of individuals who have suffered from neurological injuries or diseases, such as strokes, traumatic brain injuries, or spinal cord injuries. These devices range from wearable gadgets such as robotic exoskeletal suits to non-invasive stimulators and advanced software that assist patients in regaining lost motor functions and improving overall neurological health. The devices function through various mechanisms, such as providing repetitive motion therapy, electrical stimulation, or virtual reality environments to enhance neuroplasticity and facilitate patient engagement in their rehabilitation process. The primary advantage of neurorehabilitation devices lies in their ability to provide personalized therapy, adapt to a patient's progress, and deliver consistent treatment that can greatly improve the speed and extent of recovery. They are an essential component in modern rehabilitation regimens, offering patients a chance at increased independence and improved quality of life.

Get a Sample Copy of this Report: https://www.imarcgroup.com/neurorehabilitation-devices-market/requestsample

Market Trends:

The global neurorehabilitation devices market is majorly driven by an increasing prevalence of neurological disorders and the rising incidence of trauma-induced injuries. Along with this, advancements in technology are leading to the development of more sophisticated and effective devices, which is a significant factor contributing to market expansion. In addition, the incorporation of AI and machine learning for adaptive and predictive therapeutic regimes is a major trend within the market. Additionally, the market is experiencing a rise in demand due to the aging population, who are more prone to neurological diseases and thus require rehabilitation services.

Moreover, the growing popularity of outpatient and home healthcare services is further stimulating the market as neurorehabilitation devices become more user-friendly and accessible outside traditional clinical settings. Apart from this, investments in research and development activities to explore innovative therapeutic modalities are also propelling the market forward. Furthermore, the increasing recognition of the need for early and intensive rehabilitation post-neurological events is creating a positive market outlook.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/neurorehabilitation-devices-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Biometrics Ltd, Bioness Inc.
  • Bionik Laboratories Corp
  • BioXtreme Ltd.
  • Boston Scientific Corporation
  • Ectron Ltd
  • Ekso Bionics
  • Hocoma AG (DIH International Limited)
  • Kinestica
  • Kinova Inc.
  • Medtronic plc
  • Saebo Inc
  • Tyromotion GmbH

Neurorehabilitation Devices Market Segmentation:

Our report has categorized the market based on region, product type, application and end use.

Breakup by Product Type:

  • Neurorobotic Devices
  • Wearable Devices
  • Non-Invasive Stimulators
  • Brain-Computer Interface

Breakup by Application:

  • Stroke
  • Multiple Sclerosis
  • Parkinson's Disease
  • Cerebral Palsy
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Cognitive Care Centers
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800